Disclosures for "Phenotype Description and Lower Pathogenicity Threshold in a Large Cohort of SCA27B"
-
Dr. Iruzubieta has received personal compensation in the range of $0-$499 for serving as a Participant in an activity with UCB. Dr. Iruzubieta has received personal compensation in the range of $500-$4,999 for serving as a Teacher in a course with Health in Code.
-
Dr. Ashton has nothing to disclose.
-
Dr. Pellerin has nothing to disclose.
-
Dr. Villa has nothing to disclose.
-
Matt Danzi has nothing to disclose.
-
Marie-Josee Dicaire has nothing to disclose.
-
Ms. Aldecoa has nothing to disclose.
-
Prof. Renaud has nothing to disclose.
-
Dr. Mathieu has nothing to disclose.
-
Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Expert consultant with INESS (Quebec Public Health agency). Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Amylyx Pharmaceuticals.
-
Dr. Chalk has nothing to disclose.
-
Dr. Lafontaine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin. Dr. Lafontaine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Lafontaine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie.
-
Dr. Evoy has nothing to disclose.
-
Dr. Rioux has nothing to disclose.
-
Dr. Brisson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Brisson has received research support from Pharnext, Harmony biosciences, PepGen.
-
Author has nothing to disclose
-
Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
-
Roberta La Piana has received research support from Canadian Institute Health Research. Roberta La Piana has received research support from Ataxia Canada. Roberta La Piana has received research support from Spastic Paraplegia Foundation. Roberta La Piana has received research support from Fonds de Recherche en Santé du Quebec. Roberta La Piana has received research support from Roche Canada.
-
Dr. Duquette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata. The institution of Dr. Duquette has received research support from Actelion. The institution of Dr. Duquette has received research support from Ataxia Canada/FARA.
-
Dr. Brais has nothing to disclose.